Loading clinical trials...
Loading clinical trials...
Operational Feasibility, Impact of Additional Screening Using Highly-sensitives RDTs Combined With High Coverage of IPTp on Placental Malaria and Low Birth Weight
Conditions
Interventions
Additional screening using ultra sensitive RDTs
Dihydroartemisinin-piperaquin
+1 more
Locations
1
Burkina Faso
Institut de Recherche en Sciences de la Santé/ Clinical Research Unit of Nanoro
Ouagadougou, Kadiogo, Burkina Faso
Start Date
August 31, 2020
Primary Completion Date
August 31, 2021
Completion Date
December 31, 2021
Last Updated
March 30, 2023
NCT06068530
NCT05764746
NCT06549257
NCT03923725
NCT03996967
NCT03167242
Lead Sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions